Nazione: Svizzera
Lingua: italiano
Fonte: Swissmedic (Swiss Agency for Therapeutic Products)
erlotinibum
Mylan Pharma GmbH
L01XE03
erlotinibum
Compresse rivestite con film
erlotinibum 100 mg ut erlotinibi hydrochloridum, lactosum monohydricum 95.93 mg, cellulosum microcristallinum, carboxymethylamylum natricum A, magnesii stearas, Überzug: poly(alcohol vinylicus), E 171, macrogolum 3350, talcum, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, natrii hydrogenocarbonas, pro compresso obducto corresp. natrium 0.71 mg.
A
Synthetika
Farmaco
2021-03-09